mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
BMS-708163 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0004 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |